Location History:
- Hoover, AL (US) (2013)
- Birmingham, AL (US) (2018)
- Gaithersburg, MD (US) (2020)
- Payson, UT (US) (2019 - 2023)
Company Filing History:
4 out of 406 
3 out of 12 
1 out of 1 Years Active: 2013-2025
Title: Innovations by Kent R. Van Kampen: A Trailblazer in Biotechnology
Introduction
Kent R. Van Kampen, an accomplished inventor based in Payson, UT, has made significant contributions to the field of biotechnology. With a total of six patents to his name, he has focused on developing innovative methods and compositions that have the potential to revolutionize therapeutic and prophylactic treatments.
Latest Patents
One of his latest patents, titled "Hornfly Vaccine Methods," involves the creation of fusion proteins that include a truncated thrombostasin protein with at least 85% sequence homology to a naturally occurring thrombostasin protein, alongside non-thrombostasin protein partners. This invention aims to provide vaccine compositions that target the response to thrombostasin proteins, offering methods for preparation and administration of these fusion proteins effectively.
Another significant patent is related to "Biodegradable Polymeric Particles Encapsulating an Active Agent." This invention presents therapeutic or prophylactic compositions capable of delivering active agents, including antigens or expression vectors, encapsulated within biodegradable polymeric particles. These particles can maintain an initial release of the active agent, with structured gradients through the composite designed for delayed release periods ranging from 7 days to 6 months. This innovative approach has broad applications in pharmaceutical formulations aimed at effective patient care.
Career Highlights
Kent R. Van Kampen has contributed his expertise at several prestigious institutions, most notably Auburn University and Altimmune, Inc. His roles in these organizations have not only advanced his research but have also led to significant collaborations in the field of biotechnology.
Collaborations
Throughout his career, Kent has worked alongside notable colleagues such as De-Chu C. Tang and Haroldo E. Toro. Their combined efforts in research and development have fostered a collaborative environment that continues to push the boundaries of innovation in the industry.
Conclusion
As a distinguished inventor, Kent R. Van Kampen's patents reflect his commitment to enhancing medical treatments through groundbreaking biotechnology. His work promises to continue impacting the field positively, inspiring future innovations in vaccine development and pharmaceutical formulations.